SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from AMACORE GROUP, INC. (CIK 0000949394) — Sep 23, 2005

AMACORE GROUP, INC. (CIK 0000949394)
Date: Sept. 23, 2005 · CIK: 0000949394 · Accession: 0001167966-05-001355

AI Filing Summary & Sentiment

File numbers found in text: 333-121308

Referenced dates: September 22, 2005

Date
Sept. 23, 2005
Author
/s/
Form
CORRESP
Company
AMACORE GROUP, INC. (CIK 0000949394)

Letter

Securities and Exchange Commission (formerly Eye Care International, Inc.) Registration Statement on Form SB-2/A Filed September 15, 2005 Registration No. 333-121308

Dear Ms. Wolff:

On behalf of the registrant, we respectfully respond to your comment letter dated September 22, 2005 to Clark A. Marcus, President and Chief Executive Officer of the registrant.

COMMENT

Financial Statements

Financial statements for the six months ended June 30,

Note 8 - Convertible Debentures

1.

We note your response to our prior comment 2. Tell us how you have considered SFAS 133 and EITF 00-19 in determining that the conversion feature on your convertible debt is not an embedded derivative. In your response specifically address whether your obligation to issue shares upon conversion must be satisfied in registered shares. Additionally, tell us whether any terms in the debt agreements would require net cash settlement.

RESPONSE

The Company has reviewed FAS 133 and EITF 00-19 to determine if the convertible debt should be considered as a derivative. In particular, it has compared paragraphs 12-33 of EITF 00-19 to the convertible instrument with a view to determining if the embedded conversion feature would require bifurcation from the instrument to be considered as a standalone derivative.

In review of the paragraphs 12-33, the Company is of the opinion that it meets the tests of those paragraphs so that the embedded conversion feature would be classified as equity and not as a liability and therefore not categorized as a standalone derivative. The Company is not obligated to satisfy the obligation by issuing registered shares. There are no terms in the agreement that would require a net cash settlement.

As such, the convertible debenture and its embedded conversion feature should be accounted for under EITF 00-27. The Company has accounted for the discount associated with the conversion feature and expensed it as interest in the current period in accordance with the applicable paragraphs of EITF 00-27. Therefore, we believe that Form SB-2/A, Amendment No. 7, is correct as filed, without any further revisions.

Thank you for your prompt attention and cooperation. If any additional information is desired or if there is any question, please contact me or Mr. Marcus by telephone.

Sincerely,
/s/
David J. Levenson

Show Raw Text
CORRESP
1
filename1.htm

      Response to SEC Comments

    LAW
      OFFICES OF

    DAVID
      J. LEVENSON

    7947
      Turncrest Drive

    Potomac,
      Maryland 20854

              Admitted:
                MC, DC and VA

              (301)
                299-8092

              Fax:
                (301) 299-8093

              levensonfam@msn.com

              (Not
                Admitted: MD)

    September
      23, 2005

    Elaine
      Wolff, Branch Chief

    Securities
      and Exchange Commission

    100
      F
      Street, NE

    Washington,
      D.C. 20549

            Re:

              The
                Amacore Group, Inc.

              (formerly
                Eye Care International, Inc.)

              Registration
                Statement on Form SB-2/A

              Filed
                September 15, 2005

              Registration
                No. 333-121308

    Dear
      Ms.
      Wolff:

    On
      behalf
      of the registrant, we respectfully respond to your comment letter dated
      September 22, 2005 to Clark A. Marcus, President and Chief Executive Officer
      of
      the registrant.

    COMMENT

    Financial
      Statements

    Financial
      statements for the six months ended June 30,
      2005

    Note
      8 - Convertible Debentures

              1.

              We
                note your response to our prior comment 2. Tell us how you have considered
                SFAS 133 and EITF 00-19 in determining that the conversion feature
                on your
                convertible debt is not an embedded derivative.  In your response
                specifically address whether your obligation to issue shares upon
                conversion must be satisfied in registered shares.  Additionally,
                tell us whether any terms in the debt agreements would require net
                cash
                settlement.

    RESPONSE

    The
      Company has reviewed FAS 133 and EITF 00-19 to determine if the convertible
      debt
      should be considered as a derivative. In particular, it has compared paragraphs
      12-33 of EITF 00-19 to the convertible instrument with a view to determining
      if
      the embedded conversion feature would require bifurcation from the instrument
      to
      be considered as a standalone derivative.

    In
      review
      of the paragraphs 12-33, the Company is of the opinion that it meets the tests
      of those paragraphs so that the embedded conversion feature would be classified
      as equity and not as a liability and therefore not categorized as a standalone
      derivative. The Company is not obligated to satisfy the obligation by issuing
      registered shares. There are no terms in the agreement that would require a
      net
      cash settlement.

    As
      such,
      the convertible debenture and its embedded conversion feature should be
      accounted for under EITF 00-27. The Company has accounted for the discount
      associated with the conversion feature and expensed it as interest in the
      current period in accordance with the applicable paragraphs of EITF 00-27.
      Therefore, we believe that Form SB-2/A, Amendment No. 7, is correct as filed,
      without any further revisions.

    Thank
      you
      for your prompt attention and cooperation. If any additional information is
      desired or if there is any question, please contact me or Mr. Marcus by
      telephone.

              Sincerely,

              /s/
                David J. Levenson

              David
                J. Levenson

            cc:

              Michael
                McTiernan, Special Counsel

              Clark
                A. Marcus, President